KRAS and carcinoma: This suggests that NRAS mutations may represent early genomic events similar to KRAS mutations, but further investigation is required to determine whether NRAS mutations are more frequent in a wider context or just limited to the unique settings of our study (carcinomas arising from colorectal adenomas).